How Epstein-Barr virus triggers multiple sclerosis
A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune system to mistakenly attack the body’s nerve cells.
Sex differences in genes of mice brains
Stanford scientists found more than 1,000 gene-activation differences between female and male mice’s brains, plus more than 600 between females in different stages of their reproductive cycle.
New possible ALS genes discovered
Using machine learning, Stanford Medicine scientists and their colleagues have found hundreds of genes that could play a role in amyotrophic lateral sclerosis.
Antibodies may predict COVID-19 severity
A look at antibodies in patients soon after they were infected with the virus that causes COVID-19 showed key differences between those whose cases remained mild and those who later developed severe symptoms.
Therapeutics accelerator launched
Deerfield Management, a health care investment firm, has committed up to $130 million to support innovative translational research at Stanford.
Antibody synergy targets tough cancers
Two anti-cancer antibodies have a much stronger effect against pediatric nerve-cell and bone cancers in mice than either one alone, researchers have discovered.
Fastest genome sequencing
A research effort led by Stanford scientists set the first Guinness World Record for the fastest DNA sequencing technique, which was used to sequence a human genome in just 5 hours and 2 minutes.
Hormone treatment for transgender teens
Transgender adults who started gender-affirming hormone therapy as teens had better mental health than those who waited until adulthood or wanted the treatment but never received it, a Stanford-led study found.
New Stanford Health Care board chair
Silicon Valley entrepreneur Marc E. Jones has been a board member since 2020. He succeeds John Levin as chair.
Stanford ranks high for complex heart procedures
For patients like Nathan Foss, Stanford’s expertise in rare and complicated heart surgeries provides better options.